Ginseng and health outcomes: an umbrella review
Frontiers in Pharmacology · 03.07.2023 · 14
DOI: 10.3389/fphar.2023.1069268 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.07.2023. Verfasst von Zhongyu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Ginseng consumption has been associated with various health outcomes. However, there are no review articles summarizing these reports.
Methods
PubMed, Embase, the Cochrane Library of Systematic Reviews, Scopus, CNKI and Wanfang databases were searched from inception to 31 July 2022. The Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) and Grading of Recommendations Assessment, Development and Evaluation (GRADE) systems were used to assess the methodological quality and quality of evidence in each meta-analysis, and the results were summarized in a narrative form.
Results
Nineteen meta-analyses that met the eligibility criteria were identified from among 1,233 papers. The overall methodological quality was relatively poor, with only five studies being low-quality, and 14 critically low-quality. When compared with control treatments (mainly placebo), ginseng was beneficial for improving fatigue and physical function, sexual function, menopausal symptoms, metabolic indicators, inflammatory markers, unstable angina and respiratory diseases. Adverse events included gastrointestinal symptoms and potential bleeding; however, no serious adverse events were reported.
Conclusion
This umbrella review suggests that ginseng intake has beneficial therapeutic effects for diverse diseases. However, the methodological quality of studies needs to be improved considerably. In addition, it is imperative to establish the clinical efficacy of ginseng through high-quality randomized controlled trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Chinese Medicine, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Wang, Y., Xu, Q., Ma, J., Li, X., Tian, Y., Wen, Y., & Chen, T. (2023). Ginseng and health outcomes: an umbrella review. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1069268
Vancouver
Li Z, Wang Y, Xu Q, Ma J, Li X, Tian Y, et al. Ginseng and health outcomes: an umbrella review. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1069268
BibTeX
@article{Li2023,
author = {Li, Zhongyu and Wang, Yang and Xu, Qing and Ma, Jinxin and Li, Xuan and Tian, Yibing and Wen, Yandong and Chen, Ting},
title = {Ginseng and health outcomes: an umbrella review},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1069268}
}
EUVIMED